Hp、感染、疾病
- 格式:pdf
- 大小:320.22 KB
- 文档页数:8
HP感染治疗方案引言HP,即幽门螺杆菌(Helicobacter pylori),是一种常见的引起胃和十二指肠疾病的细菌。
它被认为是胃溃疡、胃炎和胃癌的主要诱因之一。
针对HP感染的治疗方案因其慢性感染和多重耐药性等特点而变得复杂。
本文将介绍一种常用的HP感染治疗方案。
治疗方案一线药物在治疗HP感染时,一线药物包括以下三种药物:1.贝类药物(PPI):贝类药物指质子泵抑制剂(PPI),如奥美拉唑和兰索拉唑等。
贝类药物的作用是减少胃酸分泌,从而为其他药物的发挥创造条件。
2.抗生素:抗生素是最常用的针对HP感染的药物。
常用的抗生素包括克拉霉素、阿莫西林、甲硝唑和四环素等。
抗生素的选择应基于患者耐药状态和药物的适应性。
3.胃黏膜保护药物:为了保护胃黏膜,减少药物的不良反应,常使用铋剂类药物,如枸橼酸铋钾、枸橼酸铋胶囊等。
治疗方案的选择和调整治疗HP感染的方案选择应根据患者个体情况和耐药性进行调整。
常见的治疗方案包括以下几种:1.三联疗法:三联疗法是最常用的一线治疗方案,包括贝类药物、克拉霉素和阿莫西林。
疗程一般为10-14天,具体剂量可根据患者情况进行调整。
2.四联疗法:四联疗法是用于一线治疗失败的患者的常用方案,包括贝类药物、克拉霉素、阿莫西林和甲硝唑。
疗程一般为10-14天,剂量可根据患者情况进行调整。
3.二次治疗方案:对于一线治疗失败的患者,可以尝试不同的治疗方案。
比较常用的二次治疗方案包括贝类药物、四环素和呋喃妥因的联合使用,疗程一般为10-14天。
4.个体化治疗:对于存在耐药性或特殊情况的患者,应进行个体化治疗方案的选择。
这包括选择其他抗生素、延长治疗疗程、联合使用草药治疗等。
治疗效果评估和复查治疗结束后,需要进行治疗效果评估和复查。
常用的评估方法包括以下几种:1.非侵入性检测方法:包括呼气法幽门螺杆菌呼气试验(UBT)和粪便抗原检测(Stool Antigen Test,SAT)。
2.侵入性检测方法:包括胃镜检查和组织活检。
幽门螺杆菌(Hp)的感染与治疗徐勇军药师Hp感染的危害1、目前我国Hp感染率仍高达约50%。
Hp感染者中约15%-20%发生消化性溃疡,5%-10%发生Hp相关消化不良,约1%发生胃恶性肿瘤[胃癌、胃黏膜相关淋巴组织(MALT)淋巴瘤],多数感染者并无症状和并发症,但所有Hp感染者几乎都存在慢性活动性胃炎(chronic active gastritis),即Hp胃炎。
Hp感染与慢性活动性胃炎之间的因果关系符合Koch原则。
Hp感染可以在人-人之间传播。
因此Hp胃炎不管有无症状和/或并发症,均是一种感染性疾病。
2、目前认为Hp感染是预防胃癌最重要的可控危险因素,根除Hp应成为胃癌的一级预防措施。
胃黏膜萎缩和/或肠化生发生前实施Hp根除治疗可更有效地降低胃癌发生风险。
3、阿司匹林、NSAID和Hp感染是消化性溃疡和溃疡并发症发生的独立危险因素。
Meta分析结果显示,服用NSAID增加Hp感染者发生消化性溃疡风险;服用NSAID前根除Hp可降低溃疡发生风险。
4、长期服用PPI者胃酸分泌减少,Hp定植从胃窦向胃体位移,发生胃体胃炎,增加胃体黏膜发生萎缩风险。
胃体黏膜萎缩可显著增加胃癌发生风险。
根除Hp可降低或消除长期服用PPI者胃体胃炎发生风险。
5、除上述胃肠外疾病外,Hp感染还被报道可能与其他若干疾病呈正相关或负相关。
呈正相关的疾病包括冠状动脉粥样硬化性心脏病、卒中、阿尔茨海默病、帕金森病、肥胖、结肠肿瘤和慢性荨麻疹等。
Hp感染的诊断1、临床应用的非侵入性Hp检测试验中。
尿素呼气试验是最受推荐的方法,单克隆粪便抗原试验可作为备选,血清学试验限于一些特定情况(消化性溃疡出血、胃MALT 淋巴瘤和严重胃黏膜萎缩)。
2、若患者无活组织检查(以下简称活检)禁忌。
胃镜检查如需活检,推荐快速尿素酶试验作为Hp检测方法。
最好从胃窦和胃体各取1块活检。
不推荐快速尿素酶试验作为根除治疗后的评估试验。
3、因消化不良症状行胃镜检查无明显胃黏膜病变者也应该行Hp检测,因为这些患者也可能有Hp感染。
HP感染诊治背景介绍:HP(幽门螺旋杆菌)是一种潜伏于胃黏膜中的细菌,被公认为胃炎和胃溃疡的主要致病因素之一。
该细菌的感染与许多胃疾病如胃癌的发生密切相关,因此及早诊治HP感染尤为重要。
一、HP感染的诊断方法HP感染的诊断主要通过以下几种方法:1. 血清学检测:通过检测患者血清中产生的抗体来判断是否感染HP,常见的血清学检测方法有ELISA和免疫荧光法。
这种方法简单、非侵入性,但无法明确判断感染的时间点。
2. 尿素酶呼气试验(UBT):该方法利用HP产生的尿素酶将含有尿素的试剂转化为二氧化碳,进而通过呼气中二氧化碳浓度的变化来判断是否感染HP。
UBT准确度高、操作简便,是目前最常用的HP感染诊断方法之一。
3. 组织活检:内镜下取得患者胃黏膜组织进行病理学检查,通过镜下观察HP的存在与否以及病变程度来确定感染情况。
组织活检是确诊HP感染的“金标准”,但操作复杂、有创,一般用于无法通过其他方法明确诊断的患者。
HP感染的治疗通常包括药物治疗和辅助疗法,以下是常用的治疗方法:1. 抗生素治疗:抗生素是治疗HP感染的首选。
常用的抗生素包括克拉霉素、阿莫西林、甲硝唑等。
根据具体情况,医生会选择合适的抗生素组合方案,对患者进行口服或静脉注射治疗。
抗生素治疗通常需要持续7至14天。
2. 胃酸抑制剂:由于HP感染与胃酸分泌异常有关,因此常规治疗中,胃酸抑制剂如质子泵抑制剂(PPI)也是必不可少的。
PPI能有效降低胃酸分泌,为抗生素发挥作用提供良好的环境。
3. 营养调理:患者在治疗期间需要注意饮食调理,避免辛辣、刺激性食物,以及含酒精和咖啡因的饮料。
适量进食易消化、富含维生素和蛋白质的饮食有助于胃黏膜的修复和恢复。
4. 幽门螺旋杆菌根除疗法:在抗生素治疗结束后,为了确保HP完全清除,通常需要进行幽门螺旋杆菌根除疗法。
这是一种长期口服抗生素和酸抑制剂的治疗,可持续数周甚至数月。
根除疗法的目的是防止HP的重新感染,减少胃病的复发风险。
根治HP的治疗方案概述HP(Helicobacter pylori)是一种引起胃炎、胃溃疡、胃癌等胃部疾病的细菌。
针对HP感染,应该采取综合的治疗方案,包括药物治疗和生活方式的改变。
本文将详细介绍根治HP的治疗方案。
1. 药物治疗药物治疗是治疗HP感染的主要方法。
常用的药物包括抗生素、胃酸抑制剂和胃粘膜保护剂。
下面将详细介绍这些药物的作用和使用方法。
1.1 抗生素抗生素是消灭HP细菌的主要药物。
常用的抗生素包括阿莫西林、克拉霉素、甲硝唑等。
通常采用联合用药的方式,即同时使用两种或更多种抗生素,以增加杀菌效果。
具体的联合用药方案需由医生根据患者情况进行合理选择。
1.2 胃酸抑制剂胃酸抑制剂可有效减少胃酸的分泌,减轻胃部炎症和溃疡的发生。
常用的胃酸抑制剂包括奥美拉唑、雷尼替丁等。
患者应按照医生的建议正确使用,以保证药物的疗效。
1.3 胃粘膜保护剂胃粘膜保护剂能够修复受损的胃粘膜,促进溃疡愈合,减轻症状。
常用的胃粘膜保护剂包括枸橼酸铋钾、胃复安等。
同样需要根据医生的建议正确使用。
2. 生活方式的改变除了药物治疗,改变生活方式也是根治HP的重要手段。
以下是一些建议:2.1 饮食调整避免辛辣、油腻、刺激性食物的摄入,如辣椒、酱油、烟酒等,这些食物会加重胃部炎症。
建议多食用富含维生素C和纤维素的食物,如蔬菜、水果、全谷类等,以增强免疫力和帮助胃部康复。
2.2 合理作息保持正常的作息时间,尽量避免熬夜和过度劳累。
睡眠不足和精神紧张会影响免疫力,使HP感染更难消除。
2.3 减轻压力学会有效地放松自己,减少生活中的压力。
压力过大会影响消化系统的正常功能,使胃部疾病更难治愈。
2.4 戒烟限酒吸烟和过量饮酒对胃部健康有害,容易引起胃炎和溃疡。
应坚决戒烟限酒,以预防和治疗HP感染。
3. 定期复查治疗期间,患者应定期复查以监测疗效和病情变化。
复查项目包括HP感染的检测和胃部病变的观察。
若疗效不理想,应及时与医生沟通,调整治疗方案。
HP感染治疗方案1. 简介HP(Helicobacter pylori),又称幽门螺杆菌,是一种引起胃和十二指肠疾病的细菌。
它感染人体消化道,导致胃炎、溃疡和胃癌等疾病。
HP感染常见于全球范围内,特别是发展中国家。
为了治疗和控制HP感染,制定适当的治疗方案显得至关重要。
本文将介绍一种常用的HP感染治疗方案。
2. 治疗方案HP感染治疗方案是基于三种不同类别的药物的联合使用:质子泵抑制剂(PPI)、抗生素和胃粘膜保护剂。
下面是具体的治疗方案:步骤1:选择合适的药物•质子泵抑制剂(PPI):常用的PPI包括奥美拉唑、兰索拉唑和波生坦。
这些药物可以抑制胃酸的分泌,降低胃酸对胃黏膜的刺激,有助于胃溃疡的愈合和减轻症状。
•抗生素:建议使用口服抗生素,如阿莫西林、克拉霉素和甲硝唑。
这些抗生素对HP菌有很强的杀菌作用,可以有效消灭感染的细菌。
•胃粘膜保护剂:可选择制霉菌素胶囊或硫糖铝胶囊等药物。
它们可以保护胃黏膜,减少对抗生素的刺激。
步骤2:制定治疗方案根据患者的具体情况制定治疗方案,通常的方案如下:•PPI + 两种抗生素:使用PPI药物以及两种抗生素的联合治疗,如奥美拉唑、阿莫西林和克拉霉素。
•使用药物的方式:根据医生的建议,选择合适的药物剂量和使用方式。
一般情况下,建议将药物分为2次口服,每日服用两次。
•治疗周期:常规治疗周期为14天,但根据患者具体情况,治疗周期可适当延长。
步骤3:监测治疗效果在治疗期间,应定期进行病情监测和评估,以确保治疗的有效性。
通常在治疗结束后的4-8周进行Hp菌根除试验,检查是否成功根除HP菌。
3. 注意事项在使用HP感染治疗方案时,还需要注意以下几点:•遵循医生的建议:根据医生的指导,准确用药,并按时服药,不得随意更改剂量或药物使用方式。
•注意副作用:一些抗生素可能引起不良反应,如腹泻、恶心和头痛等。
如出现严重或持续的副作用,应及时告知医生。
•不良反应监控:监测患者在治疗期间的不良反应,并及时处理。
hp的治疗方案HP(胃幽门螺杆菌)是胃疾病中常见的致病菌,会引起胃炎、胃溃疡和胃癌等疾病。
针对HP感染,医学界有多种治疗方案,可以综合运用抗生素、药物和饮食调整等方法,以达到根治效果。
本文将针对HP的治疗方案进行探讨。
首先,抗生素治疗是根治HP感染的关键措施之一。
一般采用三联疗法,即联合使用两种抗生素和一种质子泵抑制剂。
常见的抗生素包括克拉霉素、阿莫西林和甲硝唑等。
抗生素能够直接杀灭HP菌株,从而减少炎症反应和恶性程度的进一步发展。
然而,由于抗生素耐药性的产生,治疗效果有时不尽如人意,这就需要针对个体情况进行调整。
其次,药物治疗在HP感染的治疗中也起到了重要的作用。
质子泵抑制剂(PPIs)是一类可以减少胃酸生成的药物,能够减轻HP感染引起的胃痛和胃酸倒流等症状。
而胃粘液保护剂能够增加胃粘液层的厚度,减少胃黏膜受到HP伤害的可能性。
此外,还有一些辅助药物,如黄连素和复方板蓝根等,具有一定的抗HP菌作用,能够加强治疗效果。
除了药物治疗,饮食调整也是HP感染的辅助治疗手段。
首先,要有起居规律,保证充足的睡眠和休息。
此外,要避免暴饮暴食和过度进食刺激性食物,如辛辣、烟酒和浓茶等。
推荐选择清淡、易消化的食物,如蔬菜、水果和全谷类食品。
适当摄入丰富的维生素C,增强身体的抵抗力。
此外,要合理安排饮食时间,避免长时间空腹或晚餐过晚。
除了上述治疗方案,HP感染者还应该密切关注自身的身体状况。
定期进行体检、胃镜检查和HP相关的检测,以及及时就医,进行针对性的治疗。
此外,要避免因精神紧张和压力过大而导致自身免疫力下降,努力保持良好的心理状态。
在HP的治疗中,我们不仅要依赖医生的指导,还要充分了解自身的情况,并进行科学合理的治疗。
同时,定期关注医学界的研究成果和新的治疗方法,以保证治疗的及时和有效。
最重要的是,要坚持治疗过程,严格按照医嘱进行治疗,以达到根治的效果。
综上所述,针对HP感染的治疗方案涉及抗生素治疗、药物治疗、饮食调整和健康管理等多个方面。
HP感染相关性疾病核心提示:幽门螺杆菌(Helicobacter pylori,下称Hp)的发现是医学上的一件大事,也是人们对许多临床疾病特别是对上胃肠道疾病重新认识的里程碑,因而Hp的发现者Warren和Marshall荣获了2005年度诺贝尔生理学和医学奖。
一、幽门螺杆菌的发现是人们对许多上胃肠道疾病重新认识的里程碑幽门螺杆菌(Helicobacter pylori,下称Hp)的发现是医学上的一件大事,也是人们对许多临床疾病特别是对上胃肠道疾病重新认识的里程碑,因而Hp的发现者Warren和Marshall荣获了2005年度诺贝尔生理学和医学奖。
目前已经确认Hp与上胃肠道疾病中的4种疾病密切相关:①慢性胃炎;②消化性溃疡病;③胃癌;④胃黏膜相关性淋巴样组织恶性淋巴瘤(MALT淋巴瘤)。
Hp发现至现在已超过26年的历史,有关Hp与上胃肠道疾病之间关系已受到胃肠病学、微生物学、病理学、免疫学及毒理学等领域的学者或专家的极大关注。
Hp的发现使慢性胃炎和消化性溃疡病面临着一场病因学和治疗学上的革命,特别是对消化性溃疡发病机理的认识以及治疗原则发生了革命性的变化,根除Hp可以降低或预防消化性溃疡复发已被公认。
Hp是慢性活动性胃炎的重要病因,其证据符合Koch定律[1]:即病原体存在于患者体内,其存在部位与病变部位一致,清除原体病变好转,该病原体在动物体内可诱发与人相似的疾病。
1994年世界卫生组织下属的国际癌肿研究机构根据前瞻性流行病学调查资料和胃癌发生过程中的演变规律,将Hp列入I类致癌因子,因而关于Hp 与胃癌的研究也倍受人们关注。
Hp感染在MALT淋巴瘤发病中的作用也已确认,根除Hp后MALT淋巴瘤可以缩小甚至消失。
二、Hp感染已涉及多系统和多学科疾病Hp感染不仅与上胃肠道疾病相关,而且还涉及到许多胃肠道外疾病。
Hp 不仅涉及到消化疾病,而且还涉及到心脑血管、血液、内分泌、免疫、皮肤等多系统疾病,所以Hp感染是涉及多系统和多学科疾病的研究课题[3],而且涉及的胃肠道外疾病范围很广,目前已有较多的研究报道Hp感染与动脉粥样硬化、心脑血管疾病、血液系统疾病和皮肤病(如酒糟鼻、荨麻疹)、牙周疾病、儿童和胎儿的生长发育迟缓、不明原因的缺铁性贫血和特发性血小板减少性紫癜(ITP)等密切相关。
HP型病毒亚型分布及潜在感染特征HP型病毒(Human Papillomavirus,人乳头瘤病毒)是一类DNA病毒,被广泛认为是造成宫颈癌、其它生殖道癌症以及一些非生殖道病变的主要致病因素之一。
HP病毒根据其遗传物质的序列差异,可分为多个亚型。
本文将详细介绍HP型病毒亚型分布情况,并探讨其潜在感染特征。
首先,根据目前的研究,已经鉴定出超过200种HP病毒亚型。
这些亚型可以被分为低危型和高危型,根据其致癌风险的不同进行分类。
世界卫生组织(WHO)将HP型病毒亚型分为16种高危型亚型(如HPV16和HPV18等)和12种低危型亚型(如HPV6和HPV11等)。
高危型亚型主要与宫颈癌、肛门癌和口咽癌等严重疾病相关联,而低危型亚型则主要导致生殖器疣等良性病变。
HP型病毒的分布情况显示出一定的地理特点。
各地区的HP病毒亚型分布存在差异,这可能与人种、地理环境以及生活习惯等因素有关。
据研究发现,HPV16和HPV18是全球范围内最常见的高危型亚型,它们在宫颈癌中的感染率较高。
此外,研究还发现不同地区亚型的分布差异较大。
例如,在西非国家加纳,HPV18的感染率相对较高,而在中国,HPV16和HPV58则是主要感染亚型。
这些差异可能导致不同地区宫颈癌的流行程度有所不同。
除了地理差异外,HPV感染还存在一些潜在的风险和特征。
首先,HPV感染的传播途径主要是通过性接触,特别是性伴侣的频繁更替和性行为起始年龄较早等高风险行为会增加感染的概率。
此外,免疫功能下降、避孕药物使用等因素也与HPV感染的风险相关。
另外,研究发现,吸烟对HPV感染的潜在风险起到一定的促进作用,可能会增加宫颈癌发生的风险。
针对HPV感染的特点,预防和控制这一疾病的策略十分重要。
目前,疫苗接种被公认为最有效的HPV感染预防措施之一。
HPV疫苗可以预防高危型和低危型HPV亚型的感染,从而降低患上宫颈癌和其他相关疾病的风险。
此外,定期的宫颈癌筛查也是早期发现和治疗宫颈癌的重要手段。
以我给的标题写文档,最低1503字,要求以Markdown 文本格式输出,不要带图片,标题为:hp阳性怎么治疗方案# HP阳性怎么治疗方案## 简介Helicobacter pylori (HP)是一种常见的细菌,常引起胃炎、胃溃疡和胃癌等疾病。
HP 阳性是指人体内感染了HP细菌。
本文将探讨HP阳性的治疗方案。
## 检测方法要确定是否为HP阳性,可以通过以下方法进行检测:- 呼气试验:该方法检测人体呼气中是否存在HP细菌产生的尿素酶。
- 血清学检测:检测人体血清中HP的抗体水平。
- 糞便抗原检测:检测病人的糞便中是否存在HP细菌的抗原。
- 病理学检测:通过胃镜检查并取得组织样本,进行HP的病理学检测。
## 治疗方案一旦确认为HP阳性,应及时采取治疗方案来消灭该细菌,防止并发症的发生。
常用的治疗方案包括以下几种:### 三联治疗方案三联治疗方案是目前常用的HP阳性治疗方案,常规方案为使用质子泵抑制剂(PPI)和两种抗生素的联合用药。
常用的三联治疗方案包括:- PPI + 克拉霉素 + 克拉维酸- PPI + 阿莫西林 + 克拉霉素- PPI + 克拉霉素 + 甲硝唑### 四联治疗方案对于一些三联方案治疗失败的患者,可以考虑采用四联治疗方案。
常用的四联治疗方案是在三联方案的基础上加入碳酸铋胶囊(Bismuth subcitrate potassium)。
### 个体化治疗方案对于三联和四联治疗方案均无效的患者或耐药菌株存在的患者,需要进行个体化治疗。
这种治疗方案常依据药物敏感性检测结果来选择合适的抗生素进行治疗。
### 注意事项- 定期服用药物:治疗期间需要按时按量服用药物,一般持续7-14天。
- 遵守医嘱:根据医生的建议服用药物,并且不要随意更改用药方案。
- 不良反应:部分患者在治疗期间可能会有药物副作用,如胃肠道不适、头晕等,需及时咨询医生。
- 生活方式:避免酗酒、吸烟、辛辣食物以及其他刺激性食物,同时保持良好的饮食习惯和规律的作息时间。
Transactions of the Royal Society of Tropical Medicine and Hygiene(2008)102,735—742REVIEWHaptoglobin,inflammation and diseaseIsaac K.Quaye∗Department of Medical Biochemistry,University of Ghana Medical School,Korle-Bu-Accra,GhanaReceived2November2007;received in revised form3April2008;accepted3April2008Available online16May2008KEYWORDSHaptoglobin;Haemoglobin;Phenotype;Immune response;Inflammation;Infectious diseasesSummary Haptoglobin is an acute phase protein that scavenges haemoglobin in the eventof intravascular or extravascular haemolysis.The protein exists in humans as three main phe-notypes,Hp1-1,Hp2-2and Hp2-1.Accumulated data on the protein’s function has establishedits strong association with diseases that have inflammatory causes.These include parasitic(malaria),infectious(HIV,tuberculosis)and non-infectious diseases(diabetes,cardiovasculardisease and obesity)among others.Phenotype-dependent poor disease outcomes have beenlinked with the Hp2-2phenotype.The present review brings this association into perspectiveby looking at the functions of the protein and how defects in these functions associated withthe Hp2allele affect disease outcome.A model is provided to explain the mechanism,whichappears to be largely immunomodulatory.©2008Royal Society of Tropical Medicine and Hygiene.Published by Elsevier Ltd.All rightsreserved.1.IntroductionHaptoglobin(Hp)is a unique acute phase protein thatprimarily scavenges haemoglobin(Hb)released into thecirculation by haemolysis or normal red blood cell(RBC)turnover.The protein wasfirst discovered by Polonovskiand Jayle(1938)while Smithies determined the polymor-phism in the protein(Smithies and Walker,1955).The plasmaconcentration of Hp increases several fold in the eventof an inflammatory stimulus such as infection,injury ormalignancy,whether local(vascular)or systemic(extravas-cular).IL-6,produced through the activities of the primarycytokines TNF-␣and IL-1,is the major inducer of the expres-sion of the protein(Oliviero et al.,1987).∗T el.:+23321661311.E-mail addresses:dr.quaye@,akweku@.In human populations three common phenotypes arerepresented:Hp1-1,Hp2-2and the heterozygous Hp2-1,which is determined by two alleles HP1and HP2(Smithiesand Walker,1955).The HP2allele contains a partial dupli-cation of approximately1.7kb from an unequal crossingover event between HP1alleles(Maeda et al.,1984).The Hp gene transcript yields␣andprotein subunitsinterconnected by disulfide bridges after post-translationalprocessing.Inherited variations in the␣subunit give riseto the alleles that define the common phenotypes(Bowmanand Kurosky,1982).A less common phenotype is Hp2-1mod-ified(Hp2-1M),which has been observed in Africans andAfrican-Americans and results from an A-61C mutation in thepromoter region of the Hp gene(Maeda,1991).This muta-tion causes decreased gene expression in subjects with theHp2-1M phenotype.The mutation is also present in the Hp0phenotype,characterized by significantly reduced(hypo-haptoglobinaemia)or null expression(ahaptoglobinaemia)of the protein(Grant and Maeda,1993;T eye et al.,2003).In0035-9203/$—see front matter©2008Royal Society of Tropical Medicine and Hygiene.Published by Elsevier Ltd.All rights reserved.doi:10.1016/j.trstmh.2008.04.010736I.K.QuayeSoutheast Asian populations,the Hp0phenotype arises from a deletion in the promoter region of the Hp gene that gives rise to the HP del allele(Koda et al.,1998).Subjects homozy-gous for the HP del allele are ahaptoglobinaemic whilst those heterozygous are hypohaptoglobinaemic.Hp has been reported to be involved in modulating the immune response,autoimmune diseases and major inflam-matory disorders(Delanghe et al.,1999;Eaton et al., 1982;Levy,2003;Oh et al.,1990;Quaye et al.,2006). These observations appear to stem from its inherent antiox-idant property,its unique role in binding Hb and its ability to stimulate cells of the monocyte/macrophage lineage. This review summarizes current knowledge of the role of Hp in relation to inflammation and major diseases with inflammatory causes.An attempt is made to examine these relationships in terms of cause(the biochemical activities of the protein)and effect(the disease that results from dysregulation of these activities).2.Hp tissue expressionHuman Hp cDNA was originally cloned from hepatocytes, where Hp gene expression is most abundant(Yang et al., 1983).Currently,the transcript has been detected in many tissues,including white adipose tissue,brown adipose tis-sue,ovary,lungs,testis,arteries and placenta(Friedrichs et al.,1995;Kalmovarin et al.,1991;Yang et al.,1995).In humans,the induction of Hp gene expression is medi-ated primarily by IL-6,which is the common cytokine mediator for Hp gene expression in the liver of all species studied.Three IL-6-responsive regulatory regions are present on the Hp gene promoter,A-(157),B(-111)and C(-61),which together constitute the binding site for hor-mones released during the acute phase response(Baumann et al.,1990).The binding of hormones and cytokines to the regulatory regions promotes the transcription of the Hp gene and increases the synthesis of the protein.3.Hp function3.1.Antioxidant/anti-inflammatory roleUnder conditions of compromised oxygen supply,such as occurs in injury,infection or malignancy,oxygen species with free unpaired electrons are generated during mitochondrial electron transport.Referred to as highly reactive oxygen species(ROS),their production causes damage to cell mem-branes and macromolecules(lipids,proteins and DNA)(Valko et al.,2007).In addition,cells of the immune system gener-ating ROS also produce reactive nitrogen species(RNS),for example peroxynitrite(ONOO-)by the interaction between nitric oxide and superoxide,which are equally damaging to cell membranes and DNA.Cellular non-enzymatic antioxidants,which include vita-min C,vitamin E,glutathione and others,maintain cellular redox homeostasis in order to prevent or control cellu-lar damage in the event of an inflammatory response.Hp possesses an innate phenotype-dependent antioxidant activ-ity that exceeds by far that of vitamin C(ascorbic acid) (T seng et al.,2004)and contributes significantly to this pro-cess,particularly at extravascular sites.Both in vitro and in vivo studies have established that subjects with the Hp1-1 phenotype are more likely to resist cellular oxidative stress than those with the Hp2-2phenotype,with Hp2-1being intermediate(Tseng et al.,2004).The specific antioxidant functions of the protein at extravascular sites are:activation of neutrophils;maintenance of reverse cholesterol trans-port;inhibition of cyclooxygenase(COX)and lipooxygenase (LOX);and other antioxidant activities,and are described below.3.1.1.Activation of neutrophilsDuring exercise,injury,trauma or infection,the target cells secrete the primary pro-inflammatory cytokines IL-1and TNF-␣,which send signals to adjacent vascular cells to initiate activation of endothelial cells and recruitment of neutrophils.The activated neutrophils,which arefirst in the line of defence,then aid in the recruitment of other inflammatory cells following extravasation(Kushner, 1993).Neutrophils engage in generating ROS as well as recruiting other defence cells,particularly monocytes and macrophages.Hp is synthesized during granulocyte differen-tiation and stored for release when neutrophils are activated (Theilgaard-Monch et al.,2006).Neutrophil activation can occur in the absence of patent injury(during exercise) (Quindry et al.,2003).By quenching the respiratory burst, Hp assists in mitigating potential damage to the surrounding tissues.In a recent study on ischaemia/reperfusion injury and myocardial infarct size in mice,it was shown that the Hp2allele was associated with a higher level of lipid peroxi-dation products than the Hp2allele,which also boosted the expression of the antioxidant cytokine IL-10(Blum et al., 2007).The Hp2-2phenotype has consistently been observed to be a risk factor in inflammatory diseases(Delanghe et al.,1999;Levy,2004;Papp et al.,2007),attributed to its compromised antioxidant role compared to the Hp2allele.3.1.2.Maintenance of reverse cholesterol transport Elevated levels of low density lipoproteins(LDL)constitute a major risk for atherosclerosis.Oxidized LDL readily infil-trates into the arterial intima,where it is endocytosed by macrophages and eventually leads to formation of foam cells and fatty streaks(Hovingh et al.,2005).On the other hand, high density lipoproteins(HDL)play a key role in reverse cholesterol transport,together with the enzyme lecithin cholesterol acyl-transferase(LCAT).HDL in the form of Apo A-1stimulates LCAT and serves as the acceptor for the ester-ified cholesterol/phospholipid released by the enzyme.In this way,Apo A-1sustains cholesterol transport for degrada-tion in the liver,preventing its accumulation in macrophages to form foam cells.In a recent report,it was shown that Hp binds to Apo A-1to protect it from free radical-mediated damage and also prevents HDL from forming adducts with other lipoprotein molecules(Salvatore et al.,2007).This has an important health benefit in cardiovascular disease.3.1.3.Inhibition of COX and LOXArachidonic acid is the substrate for the synthesis of leukotrienes and prostaglandins(PGE)by the enzymes LOX and COX,respectively.COX is made up of two isoforms,COX1 that is constitutively expressed and COX2that is induced by stimuli including inflammation and hypoxia.Over-expressionHaptoglobin,inflammation and disease737of COX2leads to synthesis of PGE and its metabolites,throm-boxane (vasoconstrictor)and prostacyclins (vasodilator).Leukotrienes and prostaglandins participate in immunomod-ulation,upregulation of apoptotic genes,tissue growth and repair ,among others.LOX is also known to participate in oxidizing LDL,which can lead to the generation of lipid per-oxides (Palmer and Henrich,1995).Hp has been shown to inhibit both COX and LOX (using commercial Hp in guinea pigs),which provides a means to modulate responses to inflammation or infection that may be harmful to tissues (Saeed et al.,2007).3.1.4.Other antioxidant activitiesAs a molecular chaperone,Hp inhibits the inappropriate self-association of proteins induced by oxidation or heat.This function puts Hp alongside clusterin as major extracellular proteins that protect against protein misfolding,assisting in the preservation of cell function (Yerbury et al.,2005).Hp is persistently elevated in pregnancy ,myocardial infarction and obesity (Berkova et al.,2001;Blum et al.,2007;Chiellini et al.,2004).These conditions are characterized by tissue growth and repair that require anti-inflammatory responses.Hp performs this role both as a ligand for Mac-1(complement receptor type 3,CD11b/CD18)and a required factor for cell migration (de Kleijn et al.,2002)and angiogenesis (Cid et al.,1993).Tissue repair and regeneration are accomplished by collagen turnover and the movement of fibroblasts within the extracellular matrix.Hp inhibits the activities of the matrix metalloproteinases (MMP-2,MMP-9)required for the breakdown of gelatin and directly promotes the migration of fibroblasts needed for tissue regeneration (de Kleijn et al.,2002).At extravascular sites,Hp undertakes signifi-cant anti-inflammatory activities that are important for the maintenance of redox homeostasis while augmenting tissue repair (de Kleijn et al.,2002).3.2.Hb bindingHb is critical for life,providing cells with oxygen for their energy needs.However ,outside of the confines of the ery-throcytes (RBCs),Hb is highly toxic (Alayash,2004).Its prosthetic group,haem,is lipophilic and readily interca-lates into cell membranes to disrupt the lipid bilayers.Iron present in haem catalyzes the generation of ROS through the Fenton and Haber-Weiss reactions (Figure 1)(Sadrzadeh et al.,1984).Additionally ,Hb avidly binds to nitric oxide,depleting the cell of a major modulator of vascular tone,resulting in changes in vasomotor constriction and endothe-lial damage (Minneci et al.,2005).The presence of free Hb is therefore a danger signal that is very rapidly attenu-ated by mechanisms that enable rapid and efficient removal of the protein in circulation or at the site of injury .HpFigure 1Reactions associated with the generation of reactive oxygen species.binds Hb to prevent Hb-related oxidative damage and also limits the release of haem,which exacerbates oxidative stress.Hb may therefore act as a secondary modulator of the anti-inflammatory role of Hp.In general,Hb removal from the circulation following intravascular and extravascular haemolysis is accomplished by three major mechanisms:high affinity binding of Hb to Hp;high affinity binding of haem to hemopexin (Hpx);and low affinity binding of Hb to CD163.The mechanisms involving Hpx and CD163appear to function during massive or localized haemolysis,where Hp concentration is over-whelmed or limited,and this review will focus on Hp-Hb interactions.Both Hp and Hb are made up of ␣/-dimers but interac-tion to form the Hp-Hb complex occurs mostly through the chain of Hb and the chain of Hp (Ettrich et al.,2002).Equimolar amounts of Hp bind to Hb,although Hp is nor-mally present in serum in a >400molar excess compared to free Hb (Bowman and Kurosky ,1982).After forming a Hp-Hb complex,the scavenger receptor CD163expressed on the surface of monocytes and tissue macrophages enables the endocytosis of the complex,which is followed by degrada-tion in the liver and spleen (Kristiansen et al.,2001).Both the Hb binding capacity (HBC)and affinity of the Hp-Hb com-plex for CD163are phenotype dependent (Kristiansen et al.,2001).The HBC measures the capacity of an Hp phenotype to protect against a haemolytic episode (Hb-related cell dam-age and release of haem).This activity ,which is ranked in the order Hp1-1>Hp2-1>Hp2-2,partially explains the abil-ity of the phenotypes to prevent Hb-related oxidative stress (Saeed et al.,2007).3.3.ImmunomodulationIn general,an immune response may be classified as innate or adaptive (Chaplin,2006).Innate immunity predominantly carries out the post-injury response,while the innate and adaptive arms are integrated in the post-infection response (Medzhitov and Janeway ,2000).In immune modulation,cells of both arms of the immune system,upon contact with dan-ger signals,stimulate the generation of anti-inflammatory and pro-inflammatory factors to repair injured tissue or eliminate an infection,while ensuring that local cellular damage is minimized (Matzinger ,2002;Shi et al.,2003).The effectors of the immune response are cellular (phagocytes and dendritic cells)and humoral (cytokines,complement,acute phase proteins and leukotrienes)(Pillay et al.,2007).Hp has numerous roles in both the cellular and humoral activities of the innate and adaptive systems,including prostaglandin synthesis,leukocyte recruitment and migra-tion,the generation of cytokine patterns following injury and infection,and tissue repair .In the event of an injury or trauma,the acute inflam-matory response leads to the recruitment of neutrophils as the first line of defence,through activated endothelial cells and platelets (Pillay et al.,2007).The endothelial cells acti-vate COX-2,which synthesizes prostaglandin E2,increasing vasodilation and so enabling neutrophil migration.Simul-taneously ,platelets increase expression of chemokines,platelet derived growth factor (PDGF),TGF-and cytokines (IL-1,TNF-␣)for the recruitment of additional neutrophils as well as monocytes and macrophages in the chronic phase738I.K.Quaye(Kaplanski et al.,2003).This early process involves the active participation of Hp as a ligand for Mac-1(El-Ghmati et al.,1996).Although Hp is involved in the initial recruit-ment of neutrophils,it also dampens sustained neutrophil activity by inhibiting both LOX and COX(observed in guinea pigs using commercial Hp)and attenuates the respiratory burst.Since LOX is also involved in producing lipoxins,which reduce the effect of the respiratory burst(Wada et al., 2006),Hp exhibits a potent immunomodulatory role in min-imizing cellular damage in the inflammatory response.As a p53-like protein,Hp promotes the apoptosis of neutrophils as monocytes and macrophages are attracted to the site of injury(Kim et al.,1995).During the repair phase,macrophages express the chemo-attractants PDGF,MCP-1,TNF-␣,IL-1and IL-6.These stimulate the recruitment of more macrophages andfibrob-lasts to contain the inflammation and begin the wound healing process(Eming et al.,2007).Increased secretion of IL-6and TNF-␣further enhances Hp expression and aug-ments its activities,which also include inhibition of gelatin deposition and a direct effect onfibroblast migration needed for wound healing and repair(Gabay,2006).Lymphocytes are thefinal arm of the cellular immune response that contribute to achieving wound repair with limited cellu-lar damage.Specifically,the secretion of cytokines by CD4+ T H1(pro-inflammatory)and T H2(anti-inflammatory)cells is orchestrated to achieve efficient and effective wound heal-ing.A high T H1response could cause cellular damage,while a high T H2response could lead to tissuefibrosis or,in some cases,allergy(Meneghin and Hogaboam,2007).Thus proper T H1/T H2balance is an important mechanism for ensuring effective elimination of injury or an infecting organism while maintaining excellent tissue regeneration.Hp is an established suppressor of T cell proliferation, exhibiting strong inhibition of T H2cytokine release and weak inhibition of T H1cytokine release(Arredouani et al.,2003). This immunomodulatory role has been found to be pheno-type dependent.In a recent publication it was shown that macrophages,activated by phagocytosis of Hp2-2-Hb com-plex through CD163,shift the T helper cell response towards T H1cytokines,while those activated by Hp1-1-Hb complex generate T H2cytokines with an increased IL-6and IL-10 cytokine release(Guetta et al.,2007).The balance of the T cell response may be particularly important at extravas-cular sites,where the local expression of Hp would play a role in reducing damage to the surrounding tissues.At extravascular sites,immature dendritic cells interact with antigens or danger signals.Danger signals can be biomolecu-lar metabolites,including advanced glycation end products (AGEs),membrane components,uric acid and ROS(Valko et al.,2007;Bianchi,2007)or infectious signals such as cell wall components of bacteria and single stranded and double stranded RNA of viruses(Eisenacher et al.,2008).Dendritic cells are subsequently activated to mature by mast cells and move into the lymph nodes to present antigens to na¨ıve T cells,which differentiate to induce T H2or T H1cytokine responses(Wen et al.,2008).The instruction signals from mast cells tend towards T H2cytokine responses.Hp acting as a ligand for mast cells(El-Ghmati et al.,2002)may have a significant role in the dendritic cell activation process.It appears that the default cytokine profile stimulated by Hp is T H2.However,the evolution of the HP2allele seems to have modulated this function by shifting the cytokine profile towards a T H1dominant phenotype.Such an important evo-lutionary function must have been acquired following severe environmental challenges that have continued to sustain the selection of the HP2allele.4.Inflammation and HpInflammation describes the processes involved in the distur-bance of tissue homeostasis as a result of acute or chronic stimuli from an infection,stress,autoimmune reaction or mechanical injury(Gabay,2006).The homeostatic immune surveillance is largely mediated by polymorphonuclear leu-cocytes(PMN),with the disturbance eliciting PMN migration through the T H1/T H2cytokine profile(Kato and Kitagawa, 2006).Hp actively participates in all the processes from PMN recruitment and free radical quenching,to tissue repair and regeneration.Not surprisingly,the reduction or absence of Hp protein,as occurs in hypohaptoglobinemia or ahap-toglobinemia,is associated with allergic(skin and lungs)and anaphylactic transfusion reactions,respectively(Gilstad, 2003;Larsen et al.,2006;Shimada et al.,2002).A model for the role of Hp in inflammation is depicted in Figure2.In this model,danger signals stimulate Hp expression through the activity of IL-6.In Hp1-1subjects, Hp significantly reduces ROS generation through its potent antioxidant,Hb-binding and anti-inflammatory role as previ-ously elaborated.This activity then triggers a T H2-dominant response initiating healing and repair.In Hp2-2subjects, however,weak ROS quenching would allow the persistence of the inflammatory stimulus,leading to aT H1response and increased oxidative stress.Hb in this model is a modulator,as its binding to Hp reduces the generation of ROS by prevent-ing haem and iron release and also depletes the available Hp in circulation.This model could explain the effect of Hp phenotype on the progression and outcome of parasitic diseases,infectious diseases and non-infectious diseases as outlined below.5.Hp and disease associationsThe gene frequencies of the HP1and HP2alleles differ geo-graphically(Langlois and Delanghe,1996).In West Africa, East Africa and South America,the HP1allele is predomi-nant,while North America,Europe,Asia and Australia have a predominant HP2allele.The HP2allele appears to be gaining a selective advantage,having derived from the HP1allele in India(Langlois and Delanghe,1996).Hp gene polymorphism has been investigated in case-control and cross-sectional studies of several diseases in relation to their incidence and clinical expression.In particular,diseases of parasitic origin (malaria)(Atkinson et al.,2007;Elagib et al.,1998;Minang et al.,2004;Quaye et al.,2000),infectious diseases(pul-monary tuberculosis,HIV)(Delanghe et al.,1998;Kasvosve et al.,2000)and non-infectious diseases(diabetes,coronary artery disease and obesity,among others)(Chiellini et al., 2004;Levy,2004;Quaye et al.,2006)have been studied. These studies provide some insights into the role of Hp2and Hp2alleles in susceptibility/protection against infectious and non-infectious diseases and the selective advantage of the Hp2allele in various populations.Haptoglobin,inflammation and disease739Figure2Model of the role of haptoglobin(Hp)in the inflammatory response.Danger signals from stressed cells induce expression of IL-6which in turn induces expression of Hp.The strong haemoglobin(Hb)binding,antioxidant,and anti-inflammatory activity of Hp1leads to a T H2dominant cytokine expression.The corollary holds for the Hp2phenotype.ROS:reactive oxygen species.In principle,host-pathogen interaction is defined by resis-tance to(the ability to limit pathogen burden)or tolerance of(the ability to resist disease severity)a given pathogen (Raberg et al.,2007).This interaction leads to the evolu-tion of both the host and pathogen for survival.In the recent history of the evolution of the human genome,malaria has been identified as the strongest known selective pressure (Kwiatkowski,2005).The role of Hp gene polymorphism in malaria disease has been controversial.Some studies (cross-sectional and case-control)suggest that the Hp2-2 phenotype is protective against severe Plasmodium falci-parum infection and placental parasite burden(Cox et al., 2007;Elagib et al.,1998;Minang et al.,2004;Quaye et al.,2000).Other case-control studies did notfind significant associations(Aucan et al.,2002;Bienzle et al.,2005).T wo recent prospective cohort studies have also supported the view that the Hp2-2phenotype affords protection against malaria that increases significantly in children3years or older(Atkinson et al.,2007;Cox et al.,2007).It has been suggested that the presence of the A-61C mutation in the Hp promoter region,which is associated with the HP2allele,may confound genotyping for Hp0or Hp2-2phenotypes(Cox et al.,2007).This might explain, in part,the controversy over the role of the HP2and HP1 alleles in malaria protection and susceptibility.These issues notwithstanding,two questions of interest are:how might homozygosity for the HP2allele confer protection in P.falci-parum infection,while posing a risk in the predominantly inflammation-related disease states described previously and how might these influence HP2allele selective advan-tage?Functionally,the HP2allele is a weaker antioxidant, promotes iron retention,has a weaker HBC,is lower in con-centration in circulation,and in immunomodulatory function promotes a T H1-dependent cytokine profile.The cumulative effect of all of these factors could be a more pro-oxidant environment,arising from decreased quenching of ROS following infection or injury.In malaria disease,persistent haemolysis,which is also associated with the Hp2-2phe-notype(Atkinson et al.,2006)could increase ROS burden and decrease antioxidants.Eventually,sustained ROS gen-eration,to which the Plasmodium species is vulnerable, could lead to a reduction in parasite burden.This initial respiratory burst and parasite destruction might promote an accelerated processing of parasite antigens for presen-tation to na¨ıve T cells.In a malaria-endemic environment, this activity could boost host immunity over an extended period and prevent severe disease or afford immunologi-cal tolerance.In a study relating malarial anaemia and Hp genotype,it was also observed that the Hp2-2phenotype was associated with asymptomatic malaria at the end of the malaria season(Atkinson et al.,2006).Thus,the increasing prevalence of the HP2allele in both Africa and Asia(T eye et al.,2006)may be largely attributed to selective pressure from malaria,as has been the case for HbS,HbC and␣and thalassaemia.Additionally,the added shift towards T H1 cytokine profiles contributed by the HP2allele provides a balance in the immune response against pathogens,which might add to its selective advantage.In the case of non-infectious diseases(diabetes,coronary artery disease,obesity),endogenous danger signals arising from disturbed metabolic pathways and tissue damage may favour a less pro-oxidant cytokine profile as engendered by the HP1allele,thus making the HP2allele a risk factor. This scenario could similarly apply in HIV and pulmonary tuberculosis infections,where increased iron retention and reduced antioxidant factors lead to poor prognosis in sub-jects with the Hp2-2phenotype(Delanghe et al.,1998; Kasvosve et al.,2000).The Hp0phenotype is associated with anaphylactic transfusion reactions from IgG and IgE Hp anti-bodies(Gilstad,2003;Shimada et al.,2002).Hp0individuals are also at risk for iron loading in kidney proximal tubules due to glomerularfiltration of Hb(Fagoonee et al.,2005).740I.K.QuayeBased on the collective phenotype-dependent activities of Hp described here,one might propose that eventually,rou-tine screening for Hp phenotype could impact the treatment of diseases with inflammatory etiologies.6.ConclusionsHp gene polymorphism has featured prominently in dis-eases of parasitic,viral and bacterial origin.Additionally,it has been associated with non-infectious diseases involving inflammation.The unique and peculiar functional activities defined by the phenotypes make consideration of Hp phe-notypes in the clinical setting during treatment important. It also calls for intensified research to determine the pre-cise activity of the phenotypes in regulating the pro-oxidant and antioxidant environments at injury sites that lead to: inhibition or promotion of pathogen growth through antigen processing;mitigation or promotion of disease risk and/or outcome;and tissue damage or wound healing and repair. Clearly,more studies of Hp and disease associations are required,particularly with respect to its immunomodula-tory function.Studies involving Hp and parasitic diseases, as well as prospective studies with Hp knockout mice in non-infectious disease models will be valuable.Acknowledgement:The author wishes to thank Dr Eleanor G.Hankins for critically reading the manuscript.Funding:None.Conflicts of interest:None declared.Ethical approval:Not required.ReferencesAlayash,A.I.,2004.Redox biology of blood.Antioxid.Redox Signal.6,941—943.Arredouani,M.,Matthijs,P.,Van Hoeyveld,E.,Kasran,A.,Baumann,H.,Ceuppens,J.L.,Stevens, E.,2003.Haptoglobin directlyaffects T cells and suppresses T helper cell type2cytokine release.Immunology108,144—151.Atkinson,S.H.,Rockett,K.,Sirugo,G.,Bejon,P.A.,Fulford,A., O’Connell,M.A.,Bailey,R.,Kwiatkowski,D.P.,Prentice,A.M., 2006.Seasonal childhood anaemia in West Africa is associated with the haptoglobin2-2genotype.PLoS Med.3,e172. Atkinson,S.H.,Mwangi,T.W.,Uyoga,S.M.,Ogada,E.,Macharia,A.W.,Marsh,K.,Prentice,A.M.,Williams,T.N.,2007.The hap-toglobin2-2genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya.Clin.Infect.Dis.44,802—809.Aucan,C.,Walley,A.J.,Greenwood,B.M.,Hill,A.V.,2002.Hap-toglobin genotypes are not associated with resistance to severe malaria in the Gambia.Trans.R.Soc.Trop.Med.Hyg.96, 327—328.Baumann,H.,Morella,K.K.,Jahreis,G.P.,Marinkovic,S.,1990.Dis-tinct regulation of the interleukin-1and interleukin-6response elements of the rat haptoglobin gene in rat and human hepatoma cells.Mol.Cell.Biol.10,5967—5976.Berkova,N.,Lemay,A.,Dresser,D.W.,Fontaine,J.Y.,Kerizit,J., Goupil,S.,2001.Haptoglobin is present in human endometrium and shows elevated levels in the decidua during pregnancy.Mol.Hum.Reprod.7,747—754.Bianchi,M.E.,2007.DAMPs,PAMPs and alarmins:All we need to know about danger.J.Leukoc.Biol.81,1—5.Bienzle,U.,Eggelte,T.A.,Adjei,L.A.,Dietz, E.,Ehrhardt,S., Cramer,J.P.,Otchwemah,R.N.,Mockenhaupt,F.P.,2005.Lim-ited influence of haptoglobin genotypes on severe malaria in Ghanaian children.Trop.Med.Int.Health10,668—671. Blum,S.,Asaf,R.,Guetta,J.,Miller-Lotan,R.,Asleh,R.,Kre-mer,R.,Levy,N.S.,Berger,F.G.,Aronson,D.,Fu,X.,Zhang,R., Hazen,S.L.,Levy,A.P.,2007.Haptoglobin genotype determines myocardial infarct size in diabetic mice.J.Am.Coll.Cardiol.49,82—87.Bowman,B.H.,Kurosky,A.,1982.Haptoglobin:The evolutionary product of duplication,unequal crossing over,and point muta-tion.Adv.Hum.Genet.12,189—261,453—454.Chaplin,D.D.,2006.1.Overview of the human immune response.J.Allergy Clin.Immunol.117(2Suppl.Mini-Primer),S430—S435. Chiellini,C.,Santini,F.,Marsili,A.,Berti,P.,Bertacca,A.,Pelosini,C.,Scartabelli,G.,Pardini,E.,Lopez-Soriano,J.,Centoni,R.,Ciccarone,A.M.,Benzi,L.,Vitti,P.,Del Prato,S.,Pinchera,A., Maffei,M.,2004.Serum haptoglobin:A novel marker of adiposity in humans.J.Clin.Endocrinol.Metab.89,2678—2683.Cid,M.C.,Grant,D.S.,Hoffman,G.S.,Auerbach,R.,Fauci,A.S., Kleinman,H.K.,1993.Identification of haptoglobin as an angio-genic factor in sera from patients with systemic vasculitis.J.Clin.Invest.91,977—985.Cox,S.E.,Doherty,C.,Atkinson,S.H.,Nweneka,C.V.,Fulford,A.J., Ghattas,H.,Rockett,K.A.,Kwiatkowski,D.P.,Prentice,A.M., 2007.Haplotype association between haptoglobin(Hp2)and hp promoter SNP(A-61C)may explain previous controversy of hap-toglobin and malaria protection.PLoS ONE2,e362.de Kleijn,D.P.,Smeets,M.B.,Kemmeren,P.P.,Lim,S.K.,Van Midde-laar,B.J.,Velema,E.,Schoneveld,A.,Pasterkamp,G.,Borst,C., 2002.Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring.FASEB J.16,1123—1125. Delanghe,J.R.,Langlois,M.R.,Boelaert,J.R.,Van Acker,J.,Van Wanzeele,F.,van der Groen,G.,Hemmer,R.,Verhofstede,C., De Buyzere,M.,De Bacquer,D.,Arendt,V.,Plum,J.,1998.Hap-toglobin polymorphism,iron metabolism and mortality in HIV infection.AIDS12,1027—1032.Delanghe,J.,Langlois,M.,Duprez,D.,De Buyzere,M.,Clement,D., 1999.Haptoglobin polymorphism and peripheral arterial occlu-sive disease.Atherosclerosis145,287—292.Eaton,J.W.,Brandt,P.,Mahoney,J.R.,Lee Jr,J.T.,1982.Hap-toglobin:A natural bacteriostat.Science215,691—693. Eisenacher,K.,Steinberg,C.,Reindl,W.,Krug,A.,2008.The role of viral nucleic acid recognition in dendritic cells for innate and adaptive antiviral immunity.Immunobiology212,701—714. Elagib,A.A.,Kider,A.O.,Akerstrom,B.,Elbashir,M.I.,1998.Asso-ciation of the haptoglobin phenotype(1-1)with falciparum malaria in Sudan.Trans.R.Soc.Trop.Med.Hyg.92,309—311. El-Ghmati,S.M.,Van Hoeyveld, E.M.,Van Strijp,J.G.,Ceup-pens,J.L.,Stevens,E.A.,1996.Identification of haptoglobin as an alternative ligand for CD11b/CD18.J.Immunol.156, 2542—2552.El-Ghmati,S.M.,Arredouani,M.,Van Hoeyveld,E.M.,Ceuppens, J.L.,Stevens,E.A.,2002.Haptoglobin interacts with the human mast cell line HMC-1and inhibits its spontaneous proliferation.Scand.J.Immunol.55,352—358.Eming,S.A.,Brachvogel,B.,Odorisio,T.,Koch,M.,2007.Regulation of angiogenesis:Wound healing as a model.Prog.Histochem.Cytochem.42,115—170.Ettrich,R.,Brandt Jr,W.,Kopecky,V.,Baumruk,V.,Hofbauerova, K.,Pavlicek,Z.,2002.Study of chaperone-like activity of human haptoglobin:Conformational changes under heat shock condi-tions and localization of interaction sites.Biol.Chem.383, 1667—1676.Fagoonee,S.,Gburek,J.,Hirsch,E.,Marro,S.,Moestrup,S.K.,Lau-rberg,J.M.,Christensen,E.I.,Silengo,L.,Altruda,F.,T olosano,。